# Polyphron

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/polyphron

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.polyphron.com
- Total disclosed funding: $20M
- Latest round: Seed (Sep 17, 2026)
- Investors on record: 6

## About

Founded in 2024 and based in New York, US, Polyphron, Inc. is a biotechnology company that develops AI-guided tissue engineering technology to manufacture and simulate human tissues, combining stem cell biology, automated laboratory systems, and machine learning models to create functional replacement tissues for disease treatment, drug development, and regenerative medicine.

## Funding rounds

- Seed, Sep 17, 2026, $20M — Boost VC, Haystack, Gradient Ventures, Quiet Capital, Compound, Humba Ventures

## Investors

- Boost VC (https://capitalatlas.ai/funds/boost-vc) — Seed
- Haystack (https://capitalatlas.ai/funds/haystack) — Seed
- Gradient Ventures (https://capitalatlas.ai/funds/gradient-ventures) — Seed
- Quiet Capital (https://capitalatlas.ai/funds/quiet-capital) — Seed
- Compound (https://capitalatlas.ai/funds/compound) — Seed
- Humba Ventures — Seed
